Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Diamondback Sees Resilient Demand Despite Cautious Guidance
Diamondback Sees Resilient Demand Despite Cautious Guidance

Diamondback Energy Inc. (NASDAQ: FANG) stock has almost recovered all its pre-market losses after delivering its Q4 2025 earnings report on Feb. 23. The headline numbers were mixed, with a slight

NVIDIA’s AI Boom Isn’t Slowing After Blowout Q4
NVIDIA’s AI Boom Isn’t Slowing After Blowout Q4

NVIDIA’s (NASDAQ: NVDA) Q4 earnings release for its fiscal 2026 (FY2026) proves that its AI growth is far from slowing. While fears about AI spending and disruption persist, NVIDIA’s revenue

Can These 3 Names Be 2026’s Biggest Retail Comebacks?
Can These 3 Names Be 2026’s Biggest Retail Comebacks?

Nearly two months into 2026, some of the early contenders among top-performing stocks have already zipped past the broader market. This is not especially difficult to do, seeing that the S&P 500

Hycroft Mining: A High-Risk Mining Play With a Huge Potential Payoff
Hycroft Mining: A High-Risk Mining Play With a Huge Potential Payoff

The mining industry is dominated by major players with the capital and geographic reach to produce on a massive scale. Still, despite a recent cooling of the red-hot silver and gold rally, a major

Alphabet’s Quiet Edge: The Hidden Assets Powering Its Run
Alphabet’s Quiet Edge: The Hidden Assets Powering Its Run

Technology stocks have largely been driven by a narrow leadership group, the so-called Magnificent 7. Over the past 12 months, however, Alphabet (NASDAQ: GOOGL) has quietly outperformed every

ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance

ADMA Biologics ADMA reported fourth-quarter 2025 adjusted earnings per share (EPS) of 21 cents, (excluding stock-based compensation modifications, yield enhancement expense up, voluntary withdrawal

IonQ Stock Up on Q4 Earnings & Revenue Beat, Gross Margin Down
IonQ Stock Up on Q4 Earnings & Revenue Beat, Gross Margin Down

IonQ IONQ reported an adjusted loss of 20 cents per share for the fourth quarter of 2025, significantly narrower than the Zacks Consensus Estimate of a loss of 54 cents. The company posted a loss of

General Motors Recalls 43,732 SUVs Amid Software Transmission Issue
General Motors Recalls 43,732 SUVs Amid Software Transmission Issue

U.S. legacy automaker General Motors GM has issued a recall for 43,732 full-size SUVs from the 2022 model year due to a defect in their 10-speed automatic transmission. The issue involves the

Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues
Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues

Mirum Pharmaceuticals MIRM reported a loss of 11 cents per share in fourth-quarter 2025, against the Zacks Consensus Estimate of earnings of 2 cents. The company reported a loss of 49 cents per

TEM vs. ILMN: Which MedTech Stock Offers Greater Upside?
TEM vs. ILMN: Which MedTech Stock Offers Greater Upside?

In 2026, MedTech players' success will hinge on their ability to balance near-term pressure with long-term transformation. Per a report by ZS, these players must address immediate operational

Bloom Energy Outpaces Industry in YTD: How to Play the Stock?
Bloom Energy Outpaces Industry in YTD: How to Play the Stock?

Shares of Bloom Energy Corporation BE have gained 103.9% in the year-to-date (“YTD”) period compared with the Zacks Alternative Energy - Other industry’s rally of 19.5%. The company has also

EMCOR's Q4 Earnings & Revenues Beat Estimates, Operating Margin Up Y/Y: https://staticx-tuner.zacks.com/images/articles/main/a7/142346.webp
EMCOR's Q4 Earnings & Revenues Beat Estimates, Operating Margin Up Y/Y

EMCOR Group, Inc. EME reported impressive fourth-quarter 2025 results, with adjusted earnings and revenues topping the Zacks Consensus Estimate and increasing year over year.Following the results

Sempra Energy's Q4 Earnings Top Estimates, Revenues Fall Y/Y
Sempra Energy's Q4 Earnings Top Estimates, Revenues Fall Y/Y

Sempra Energy SRE reported fourth-quarter 2025 adjusted earnings per share (EPS) of $1.28, which beat the Zacks Consensus Estimate of $1.13 by 13.3%. However, the bottom line decreased 14.7% from

Weekly Jobless Claims Remain Tame, More Q4 Earnings Beats: https://staticx-tuner.zacks.com/images/articles/main/2e/148349.webp
Weekly Jobless Claims Remain Tame, More Q4 Earnings Beats

Thursday, February 26th, 2026Pre-market indexes are swinging back into positive territory from lower early-morning levels, now erasing the big losses in the first part of this week on all but the

Shopify vs. Etsy: Which E-Commerce Stock is the Smarter Buy Now?
Shopify vs. Etsy: Which E-Commerce Stock is the Smarter Buy Now?

Shopify SHOP and Etsy ETSY are established players in the rapidly expanding e-commerce space. Shopify continues to strengthen its position by equipping merchants with a comprehensive commerce stack

BRK.B Trading at a Discount to 52-Week High: What Should Investors Do?
BRK.B Trading at a Discount to 52-Week High: What Should Investors Do?

Shares of Berkshire Hathaway Inc. BRK.B closed at $493.99 on Wednesday, an 8.9% discount to its 52-week high of $542.07. BRK.B stock has lost 1.8% year to date compared with the industry’s 1.4% and

Sterling Q4 Earnings & Revenues Beat Estimates, Stock Up
Sterling Q4 Earnings & Revenues Beat Estimates, Stock Up

Sterling Infrastructure, Inc. STRL reported impressive fourth-quarter 2025 results, wherein adjusted earnings and revenues surpassed the Zacks Consensus Estimate and increased year over year.

The

IRWD Q4 Earnings and Revenues Fall Shy of Estimates, Stock Tanks
IRWD Q4 Earnings and Revenues Fall Shy of Estimates, Stock Tanks

Ironwood Pharmaceuticals IRWD reported an adjusted loss of 1 cent per share for the fourth quarter of 2025, against the Zacks Consensus Estimate of earnings of 2 cents. The company had reported

Can GE's Growth Investments Create Long-Term Value for Investors?
Can GE's Growth Investments Create Long-Term Value for Investors?

GE Aerospace GE remains focused on strengthening its growth pipeline through investments in lucrative projects. The company has been on track to invest more than $1 billion in its Maintenance

Can First Majestic's Higher Silver Production Boost Its Long-Term Growth?
Can First Majestic's Higher Silver Production Boost Its Long-Term Growth?

First Majestic Silver Corp. AG is benefiting from strong growth in silver production, supported by higher prices. In fourth-quarter 2025, the company produced 7.8 million silver-equivalent (AgEq)

Stride vs. Chegg: Which EdTech Stock has the Better Upside Now?: https://staticx-tuner.zacks.com/images/articles/main/87/142115.webp
Stride vs. Chegg: Which EdTech Stock has the Better Upside Now?

Amid a favorable demand environment for digital learning solutions, AI-based alternatives and career-focused learning, the United States education market is witnessing growth from the recently

Hormel Foods Q1 Earnings Beat Estimates, Sales Increase Y/Y
Hormel Foods Q1 Earnings Beat Estimates, Sales Increase Y/Y

Hormel Foods Corporation HRL reported first-quarter fiscal 2026 results, with the top line increasing year over year while missing the Zacks Consensus Estimate. The bottom line declined year over

Can Snapdragon 8 Elite Gen 5 for Galaxy Launch Boost QCOM Shares?
Can Snapdragon 8 Elite Gen 5 for Galaxy Launch Boost QCOM Shares?

Qualcomm Incorporated QCOM has launched its most advanced mobile chip, the Snapdragon 8 Elite Gen 5 for Galaxy, strengthening its long-running partnership with Samsung Electronics. The new

The Zacks Analyst Blog Highlights SAP, Linde, Parker-Hannifin, Daily Journal and Espey
The Zacks Analyst Blog Highlights SAP, Linde, Parker-Hannifin, Daily Journal and Espey

For Immediate Release

Chicago, IL – February 26, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Sarepta Q4 Loss Wider Than Expected, Sales Beat Estimates
Sarepta Q4 Loss Wider Than Expected, Sales Beat Estimates

Sarepta Therapeutics, Inc. SRPT reported a fourth-quarter 2025 adjusted loss of $3.58 per share, wider than the Zacks Consensus Estimate of a loss of 71 cents. This higher-than-anticipated loss was